01Jan 2025
TORS Shows Promise in Salvaging Recurrent Head and Neck Cancers

TORS Shows Promise in Salvaging Recurrent Head and Neck Cancers

Transoral robotic surgery (TORS) offers promising survival outcomes in treating recurrent, residual, and second primary head and neck cancers. This systematic review of 515 patients found two-year overall survival (73.8%) and disease-free survival (56.1%). Compared to primary cancer, OS and DFS risk ratios were significantly lower. TORS showed decreased morbidity and mortality, with a low rate of long-term complications, making it a viable option over traditional open surgery for previously irradiated fields.

  • #ent
  • #oncology

Like

Save

Share